HomeAKTX • NASDAQ
add
Akari Therapeutics PLC
Previous close
$1.19
Day range
$1.17 - $1.20
Year range
$1.08 - $5.50
Market cap
9.43M USD
Avg Volume
17.38K
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.80M | -36.84% |
Net income | -3.50M | -1.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.80M | 36.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.84M | -70.98% |
Total assets | 4.36M | -68.52% |
Total liabilities | 4.58M | -61.93% |
Total equity | -229.00K | — |
Shares outstanding | 7.92M | — |
Price to book | -39.67 | — |
Return on assets | -218.04% | — |
Return on capital | 4,146.51% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.50M | -1.71% |
Cash from operations | -3.43M | 12.97% |
Cash from investing | — | — |
Cash from financing | 1.76M | -72.78% |
Net change in cash | -1.67M | -165.42% |
Free cash flow | -2.07M | 40.92% |
About
Founded
2004
Headquarters
Website
Employees
9